WST

West Pharmaceutical Services, I WST

$358.41 -0.83 (-0.23%)

Neutral · +0.75σ

+ Compare Open in Sniper

Mkt cap $25.4B

P/E 48.1

Day $356.28 – $361.10

52wk $223.83 – $367.66

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

At a glance

West Pharmaceutical Services, I is a healthcare company listed in the US.

WST last traded at $358.41, down 0.2% on the day; that's in the upper part of its 52-week range ($223.83–$367.66). Right now it's trading close to its recent average, with no strong stretch in either direction.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.

A quick snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $175.15 (fair range $78–$175); today's price sits 105% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Strong. Model estimates only — do your own due diligence.

Overvalued -105% margin of safety Accounting: Strong

Intrinsic (DCF)

$175.15

Fair-value range

$78.04 – $175.15

Margin of safety

-105%

Accounting quality Strong

✓ More cash than debt
✓ Quick ratio 1.67 (antifragile)
✓ Current ratio 3.02 (antifragile)
✓ Debt/equity 0.34 (antifragile)

⚠ Inventory growing faster than revenue

Price implies ~34% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

WST is a $25.4 billion company, priced at 48× last year's earnings, and the stock is trading near the top of its 52-week range.

Market cap $25.4B

P/E ttm 48.1

Beta —

52w range $223.83 – $367.66

Avg volume —

Dividend yield —

Sector Healthcare

Next earnings —

52-week range · today's price

$223.83$367.66